Key Highlights
•
A new brain imaging biomarker called the DLB-related pattern (DLBRP) can accurately diagnose dementia with Lewy bodies (DLB) and even detect it in its early, pre-dementia stage. This tool helps doctors distinguish DLB from Alzheimer’s disease, leading to more accurate diagnoses and better-targeted treatments for patients.
Source →
•
A home-based sleep intervention for people with dementia and their caregivers was shown to improve sleep problems for up to two years. This long-term benefit suggests the program could be widely implemented to help manage a common and distressing symptom of dementia.
Source →
•
A large study found that for children with a type of chronic eye inflammation not linked to arthritis, starting treatment with the drug adalimumab was more effective than starting with methotrexate. This finding could change treatment guidelines, especially for children with more severe forms of the disease affecting the back of the eye.
Source →
•
Researchers have identified a new molecular pathway involving SEMA3C and PLXND1 that drives the excessive scar tissue formation in keloids. Targeting this pathway could lead to new treatments for these painful and disfiguring skin growths that currently have limited options.
Source →
•
A study analyzing the severity of birth defects linked to common painkillers found that most, like acetaminophen alone, were not associated with severe defects, but combinations with certain opioids like hydrocodone showed higher risks. This information helps doctors and patients make safer choices about pain relief during early pregnancy.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
